Clinical trials
Phase 1/2 Medulloblastoma trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2004 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2024 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Terminated | 6 |
| Recruiting | 3 |
| Active, not recruiting | 1 |
| Suspended | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Duke University | 4 |
| National Cancer Institute (NCI) | 3 |
| Bristol-Myers Squibb | 1 |
| City of Hope Medical Center | 1 |
| Eli Lilly and Company | 1 |
| Giselle Sholler | 1 |
| Hoffmann-La Roche | 1 |
| Lawrence Recht | 1 |
| Nationwide Children's Hospital | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Medulloblastoma | 22 |
| Glioma | 11 |
| Neuroblastoma | 10 |
| Central Nervous System Neoplasms | 8 |
| Astrocytoma | 7 |
| Ependymoma | 7 |
| Glioblastoma | 7 |
| Brain Neoplasms | 6 |
| Neuroectodermal Tumors, Primitive | 6 |
| Oligodendroglioma | 6 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.